1 Presentation title - edit in the Master slide 1 Current Investment Opportunities Professor Rory Shaw, Medical Director, Healthcare UK, UKTI

2 Cambridge Biomedical Campus Opportunity Innovation Centre housing 50 bio medical R&D SMEs Investment needed £30m Investor rationale Ownership and naming rights to building £1.5m p.a. net income Access to world leading medical research hub Supporting the discovery and development of pioneering, commercial biomedical research Here today: Mug shot [James Dancy UKTI]

3 Manchester Centre for Cancer Biomarker Sciences Opportunity Research centre for personalised medicine Investment needed £35m Investor rationale Partnering and collaboration with Manchester Cancer Research Centre Opportunity to invest in spin- outs Flexibility of focus on investor research interests Training and development opportunities Here today: Mug shot Peter Trainer

4 University College London Hospitals (UCLH) – Proton Beam Therapy OpportunityUCLH private PBT facility Investment needed £20-30m Investor rationale Partnership in a professionally managed private PBT facility Commercial return from facility Potential to leverage wider UCLH facilities and capabilities including 3 other PBT rooms funded by DoH Relationship with industry leading university hospital Here today: Mug shot [James Dancy - UKTI]

5 King’s Futures – Innovation and Translation Opportunity 1)New Health Innovation & Translation Centre as well as 2) Student Housing Development Investment needed £235 million Investor rationale Focus on global health challenges; including, obesity, diabetes, dental decay, cardiovascular disease (CVD), AIDS. Blended RoI on both elements Financial returns on new health treatments (spin-outs & licences) Secure return on London housing Societal returns tailored to investor Here today: Mug shot Professor Nigel Pitts

6 University of Dundee – DRIVE Opportunity Dundee Research & Infrastructure Venture is an investment proposition in the commercial exploitation of drug discovery innovation combined with revenue bearing infrastructure assets, both from the University of Dundee. Investment needed £70 million Investor rationale Fund IRR of 16.4%. Fund drawn down over 10 years and investors will take an 80% share of out-licencing returns. £35M property loan component will be included in the DRIVE package with a fixed rate of interest of 4.5%. Here today: Mug shot Neil Crabb

7 Edinburgh BioQuarter Opportunity Co-location of commercial activity alongside world class academic, clinical research and state-of-the-art 900-bed teaching hospital creates the opportunity to increase innovation, collaboration, entrepreneurship and commercialisation. Investment needed £250m in total Investor rationale Accommodation for 6,000 jobs on site by year 25 >£50m industry collaborations secured to date Pipeline of spin out companies Development and growth of expertise in: - Translational medicine - Regenerative medicine - Healthcare informatics and personalised medicine 100 acre development site Here today: Mug shot Fiona Jefferson

8 National Centre for Ageing Science and Innovation Opportunity Outline Investment on the Campus for Ageing and Vitality in Newcastle upon Tyne Investment needed £20m - £100m Investor rationale Centre announced by the Chancellor in 2014, The Campus is a globally unique, integrated environment where world- class scientific, medical, social and technological solutions are being forged to address the needs and opportunities of an ageing population. Gaining first mover advantage in this growing market can expect to see significant return on investment. Here today: Mike Morgan

9 Lancaster University – Health Innovation Campus Opportunity Outline A campus providing for the highest quality research, education and innovation where University, health and social care providers and businesses work together Investment needed £10m Investor rationale Help Saudi businesses understand the needs of the UK health system. e.g. through a series of placements. Developing ‘early knowhow’ in the field of potential innovations to support ageing populations Training opportunities for clinical staff from Saudi. Providing a ‘model’ that can be applied in Saudi. Here today: Dion Williams Director Enterprise & Innovation

10 UK Fund Catalysing Dementia Research Opportunity Outline Fund investing in research into the causes and treatment of dementia. The fund aims to involve major corporate partners and leading research institutes. Investment needed £ m. Requirement can be discussed Investor rationale Opportunity to invest alongside UK Government and multi- national healthcare companies. Dementia affects an estimated 44 million people worldwide, a figure set almost to double every 20 years as populations age in many countries. The focus of this fund will accelerate our understanding and treatment of this disease. Here today: Image [James Dancy - UKTI] This is not a statement of government policy

11 Thank you and please get in touch James Dancy, Head of Science and Innovation, UKTI Professor Rory Shaw, Medical Director, Healthcare UK, UKTI